Prosight Management’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-52,023
Closed -$1.1M 48
2021
Q2
$1.1M Buy
+52,023
New +$1.04M 0.69% 32
2020
Q1
Sell
-279,390
Closed -$2.53M 48
2019
Q4
$2.53M Buy
+279,390
New +$2.27M 1.11% 26

Other funds holding EVH

Prosight Management's EVH Position: Q3 2021 in Review

Prosight Management sold out of Evolent Health (EVH) in Q3 2021, closing a stake of 52,023 shares — an estimated $1.1M sold.

Prosight Management first reported a position in EVH in Q4 2019 and held it in 2 quarters. The position peaked at $2.53M in Q4 2019. 209 funds tracked by Wall St. Rank hold EVH as of Q3 2021.

  • Prosight Management reported no remaining Evolent Health position as of Q3 2021 after selling out during the quarter.
  • Prosight Management sold 52,023 Evolent Health shares in Q3 2021, an estimated $1.1M.
  • Prosight Management first reported a position in Evolent Health in Q4 2019 and held it in 2 quarters.
  • Prosight Management's Evolent Health position peaked at $2.53M in Q4 2019.
  • 209 funds tracked by Wall St. Rank held Evolent Health as of Q3 2021.

Based on Prosight Management's 13F filing for Q3 2021, filed 12 Nov 2021.